Your Health, We Care
Release date: 2026-05-14 15:49:11 Article From: Lucius Laos Recommended: 17
Always follow your doctor's instructions when taking ritlecitinib. The recommended dose is 50 mg (one capsule) once daily, taken orally. Swallow the capsule whole with a full glass of water. Do not open, crush, or chew the capsule before swallowing, as this may change the actual amount of drug absorbed by your body, affecting efficacy or increasing the risk of side effects. You may take it with or without food. Take it at the same time each day to help maintain stable drug levels in your blood. If you are unsure how to take it, please consult your doctor or pharmacist.
If you forget to take a dose, take it as soon as you remember. However, if it is within 8 hours of your next scheduled dose, skip the missed dose and take your next dose at the regular time. Do not take a double dose to make up for the missed one, as this increases the risk of side effects. If you accidentally take more than your prescribed dose of ritlecitinib, contact your doctor immediately, as you may experience the side effects mentioned below. If you need to interrupt treatment for a short time (no more than 6 weeks), the risk of scalp hair loss is low, but do not stop taking the medication without discussing it with your doctor first.
Any medication can cause side effects, and ritlecitinib is no exception, though not everyone gets them. Seek immediate medical attention if you experience signs of the following serious side effects: shingles (painful blistering rash, with or without fever), hives (itchy rash). Common side effects (may affect up to 1 in 10 people) include: nasal, throat, or airway infections; diarrhea; dizziness; acne; rash other than hives or shingles; folliculitis (inflamed, swollen hair follicles that may be itchy or painful); and elevated creatine kinase levels seen in blood tests. Uncommon side effects (may affect up to 1 in 100 people) include: low platelet count, low lymphocyte count, elevated liver enzymes. Report any side effects to your doctor or pharmacist, or directly via the national adverse drug reaction reporting system. Your report helps increase safety information about this medicine.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：3322025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5422024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3242025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3392025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3172025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3722025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3122025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2912025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
